Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
19 participants
INTERVENTIONAL
2019-02-04
2023-11-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tele BCI-FES for Upper -Limb Stoke Rehabilitation
NCT05215522
Feasibility and Effectiveness of tDCS in the Treatment of Post-stroke Fatigue (EFECTS).
NCT06149897
Remote Ischemic Conditioning in Patients With Acute Stroke (RESIST)
NCT03481777
Remote Ischemic Conditioning for Acute Moderate Posterior Ischemic Stroke
NCT06931535
Treatment of Post Stroke Fatigue With a Wakefulness Promoting Agent
NCT01800097
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Remote ischaemic conditioning (RIC) is a procedure whereby ischaemia is induced to a limb for short periods of time by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg). This procedure is performed for periods that avoid physical injury to the limbs, but induce neurohormonal, systemic or vascular changes in the body. Such changes often result in improved collateralisation of blood supply to various areas of the body, as well as improved efficiencies of cellular metabolism. This may enhance the physical abilities of patients undergoing rehabilitation after stroke, particularly when aiming to improve endurance and fatigue.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Remote Ischaemic Conditioning
4 cycles of 5 minutes of upper or lower (depending on tolerability) limb ischaemia followed by 5 minutes of reperfusion. This will be delivered using a manual shygnomanometer applied to the upper arm or leg and activated to go through 4 such cycles automatically. The blood pressure cuff in the active treatment arm will inflate to 200 mmHg (arm) and 220 mmHg (leg). RIC will be completed 3 times weekly for 4 weeks.
Remote Ischaemic Conditioning
Induced ischaemia to a limb by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg).
Sham Intervention
4 cycles of 5 minutes of upper or lower (depending on tolerability) limb ischaemia followed by 5 minutes of reperfusion. This will be delivered using a manual shygnomanometer applied to the upper arm or leg and activated to go through 4 such cycles automatically. The arm and leg blood pressure cuffs in the sham intervention will inflate to 20mmHg. Sham will be completed 3 times weekly for 4 weeks.
Sham Intervention
The sham intervention will inflate pressure cuffs to much lower levels for the same number of cycles.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Remote Ischaemic Conditioning
Induced ischaemia to a limb by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg).
Sham Intervention
The sham intervention will inflate pressure cuffs to much lower levels for the same number of cycles.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Symptoms of debilitating fatigue for at least 4 weeks (fatigues severity score of 28 or more).
Exclusion Criteria
* History or presence of complex neuropathic pains or peripheral neuropathy in the arms.
* Presence of lymphoedema in the arms.
* Presence of skin ulceration to the arms.
* Hospitalisation for cardiovascular or cerebrovascular disease within the last 4 weeks.
* Uncontrolled arrhythmia, hypertension, diabetes or angina.
* Third degree heart block or progressive heart failure.
* Acute aortic dissection, myocarditis, or pericarditis.
* Acute deep vein thrombosis, pulmonary embolism or pulmonary infection.
* Suspected or known dissecting aneurysm.
* Uncontrolled visual or vestibular disturbance.
* Known or suspected cause of fatigue e.g. obstructive sleep apnoea (Epworth \> 15), depression (PHQ-9 \> 14).
* Modified Rankin Score \> 4.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sheffield Teaching Hospitals NHS Foundation Trust
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ali Ali
Role: PRINCIPAL_INVESTIGATOR
Sheffield Teaching Hospitals NHS Foundation Trust
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Royal Hallamshire Hospital, Sheffield Teaching Hospitals NHS Foundation Trust
Sheffield, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STH19508
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.